» Articles » PMID: 38987295

Bioengineered Niches That Recreate Physiological Extracellular Matrix Organisation to Support Long-term Haematopoietic Stem Cells

Abstract

Long-term reconstituting haematopoietic stem cells (LT-HSCs) are used to treat blood disorders via stem cell transplantation. The very low abundance of LT-HSCs and their rapid differentiation during in vitro culture hinders their clinical utility. Previous developments using stromal feeder layers, defined media cocktails, and bioengineering have enabled HSC expansion in culture, but of mostly short-term HSCs and progenitor populations at the expense of naive LT-HSCs. Here, we report the creation of a bioengineered LT-HSC maintenance niche that recreates physiological extracellular matrix organisation, using soft collagen type-I hydrogels to drive nestin expression in perivascular stromal cells (PerSCs). We demonstrate that nestin, which is expressed by HSC-supportive bone marrow stromal cells, is cytoprotective and, via regulation of metabolism, is important for HIF-1α expression in PerSCs. When CD34 HSCs were added to the bioengineered niches comprising nestin/HIF-1α expressing PerSCs, LT-HSC numbers were maintained with normal clonal and in vivo reconstitution potential, without media supplementation. We provide proof-of-concept that our bioengineered niches can support the survival of CRISPR edited HSCs. Successful editing of LT-HSCs ex vivo can have potential impact on the treatment of blood disorders.

Citing Articles

Hematopoietic stem cells: Understanding the mechanisms to unleash the therapeutic potential of hematopoietic stem cell transplantation.

Aljagthmi A, Abdel-Aziz A Stem Cell Res Ther. 2025; 16(1):60.

PMID: 39924510 PMC: 11809095. DOI: 10.1186/s13287-024-04126-z.


Surface-Modified Piezoelectric Copolymer Poly(vinylidene fluoride-trifluoroethylene) Supporting Physiological Extracellular Matrixes to Enhance Mesenchymal Stem Cell Adhesion for Nanoscale Mechanical Stimulation.

Donnelly H, Sprott M, Poudel A, Campsie P, Childs P, Reid S ACS Appl Mater Interfaces. 2023; .

PMID: 37718477 PMC: 10636716. DOI: 10.1021/acsami.3c05128.

References
1.
Burns R, Leal J, Sullivan R, Luengo-Fernandez R . Economic burden of malignant blood disorders across Europe: a population-based cost analysis. Lancet Haematol. 2016; 3(8):e362-70. DOI: 10.1016/S2352-3026(16)30062-X. View

2.
Granot N, Storb R . History of hematopoietic cell transplantation: challenges and progress. Haematologica. 2020; 105(12):2716-2729. PMC: 7716373. DOI: 10.3324/haematol.2019.245688. View

3.
Zon L . Intrinsic and extrinsic control of haematopoietic stem-cell self-renewal. Nature. 2008; 453(7193):306-13. DOI: 10.1038/nature07038. View

4.
Yang L, Bryder D, Adolfsson J, Nygren J, Mansson R, Sigvardsson M . Identification of Lin(-)Sca1(+)kit(+)CD34(+)Flt3- short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated transplant recipients. Blood. 2004; 105(7):2717-23. DOI: 10.1182/blood-2004-06-2159. View

5.
Dexter T, Moore M, Sheridan A . Maintenance of hemopoietic stem cells and production of differentiated progeny in allogeneic and semiallogeneic bone marrow chimeras in vitro. J Exp Med. 1977; 145(6):1612-6. PMC: 2180693. DOI: 10.1084/jem.145.6.1612. View